Development of myelofibrosis in mice genetically impaired for GATA-1 expression (GATA-1low mice)

Blood

Volumn 100, Issue 4, 2002, Pages 1123-1132

  Vannucchi, Alessandro Maria ^a,b,c,d   Bianchi, Lucia ^a,b,c,d   Cellai, Cristina ^a,b,c,d   Paoletti, Francesco ^a,b,c,d   Rana, Rosa Alba ^a,b,c,d   Lorenzini, Rodolfo ^a,b,c,d   Migliaccio, Giovanni ^a,b,c,d   Migliaccio, Anna Rita ^a,b,c,d  

^a UNIVERSITY OF FLORENCE   (Italy)

^b CAREGGI UNIVERSITY HOSPITAL   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

^d ISTITUTO SUPERIORE DI SANITÀ   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

OSTEOCALCIN; PLATELET DERIVED GROWTH FACTOR; TRANSCRIPTION FACTOR GATA 1; TRANSFORMING GROWTH FACTOR BETA1; VASCULOTROPIN;

ANEMIA; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; HEMATOPOIETIC SYSTEM; MOUSE; MYELOFIBROSIS; NONHUMAN; PATHOGENESIS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SURVIVAL;

EID: 0037103206     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood-2002-06-1913     Document Type: Article

References (43)

1. Myelofibrosis with myeloid metaplasia: Diagnostic definition and prognostic classification for clinical studies and treatment guidelines
2. Myelofibrosis with myeloid metaplasia
3. Agnogenic myeloid metaplasia
4. Transforming growth factor-beta and megakaryocytes in the pathogenesis of idiopathic myelofibrosis
5. The role of transforming growth factor-beta in PEG-rHuMGDF induced reversible myelofibrosis in rats
6. Thrombopoietin: The primary regulator of platelet production
7. Transgenic mice overexpressing human c-mpl ligand exhibit chronic thrombocytosis and display enhanced recovery from 5-fluorouracil or antiplatelet serum treatment
8. Chronic exposure to retroviral vector-encoded MGDF (mpl-ligand) induces lineage-specific growth and differentiation of megakaryocytes in mice
9. A model of myelofibrosis and osteosclerosis in mice induced by overexpressing thrombopoietin (mpl ligand): Reversal of disease by bone marrow transplantation
10. High thrombopoietin production by hematopoietic cells induces a fatal myeloproliferative syndrome in mice
11. Adenovectormediated expression of human thrombopoietin cDNA in immune-compromised mice: Insights into the pathophysiology of osteomyelofibrosis
12. Autonomous megakaryocyte growth in essential thrombocythemia and idiopathic myelofibrosis is not related to a c-mpl mutation or to an autocrine stimulation by Mpl-L
13. Transcription factors that regulate lineage decisions
14. Dysregulated expression of GATA-1 following retrovirus-mediated gene transfer into murine hematopoietic stem cells increases erythropoiesis
15. Erythroid differentiation in chimaeric mice blocked by a targeted mutation in the gene for transcription factor GATA-1
16. Arrested development of embryonic red cell precursors in mouse embryos lacking transcription factor GATA-1
17. An upstream, DNase I hypersensitive region of the hematopoietic-expressed transcription factor GATA-1 gene confers developmental specificity in transgenic mice
18. A lineage-selective knockout establishes the critical role of transcription factor GATA-1 in megakaryocyte growth and platelet development
19. Consequences of GATA-1 deficiency in megakaryocytes and platelets
20. A "knockdown" mutation created by cis-element gene targeting reveals the dependence of erythroid cell maturation on the level of transcription factor GATA-1
21. Accentuated response to phenylhydrazine and erythropoietin in mice genetically impaired for their GATA-1 expression (GATA-1(low) mice)
22. Cell dose and speed of engraftment in placental/umbilical cord blood transplantation: Graft progenitor cell content is a better predictor than nucleated cell quantity
23. Stem cell factor induces proliferation and differentiation of highly enriched murine hematopoietic cells
24. Complete replacement of serum in primary cultures of erythropoietin-dependent red cell precursors (CFU-E) by albumin, transferrin, iron, unsaturated fatty acid, lecithin and cholesterol
25. Two-factor requirement for murine megakaryocyte colony formation
26. Identification and characterization of a bipotent (erythroid and megakaryocytic) cell precursor from the spleen of phenylhydrazine-treated mice
27. Pluripotent hematopoietic stem cells contain high levels of mRNA for c-kit, GATA-2, p45 NF-E2, and c-myb and low levels or no mRNA for c-fms and the receptors for granulocyte colony-stimulating factor and interleukins 5 and 7
28. mRNA expression of type I and type II receptors for activin, transforming growth factorbeta, and bone morphogenetic protein in the murine erythroleukemic cell line, F5-5.fl
29. Retinal VEGF mRNA measured by SYBR green I fluorescence: A versatile approach to quantitative PCR
30. Numerous growth factors, cytokines, and chemokines are secreted by human CD34(+) cells, myeloblasts, erythroblasts, and megakaryoblasts and regulate normal hematopoiesis in an autocrine/paracrine manner
31. Expression of IL-5 alters bone metabolism and induces ossification of the spleen in transgenic mice
32. Increased expression of the distal, but not of the proximal, Gatal transcripts during differentiation of primary erythroid cells
33. Stem cell factor induces proliferation and differentiation of fetal progenitor cells in the mouse
34. Molecular bases of dominant negative and loss of function mutations at the murine c-kit/white spotting locus: W37, Wv, W41 and W
35. Cloning of cDNA for the major DNA-binding protein of the erythroid lineage through expression in mammalian cells
36. Familial dyserythropoietic anaemia and thrombocytopenia due to an inherited mutation in GATA1
37. Platelet characteristics in patients with X-linked macrothrombocytopenia because of a novel GATA1 mutation
38. X-linked thrombocytopenia caused by a novel mutation of GATA-1
39. X-linked thrombocytopenia with thalassemia due to mutation in the aminofinger of GATA-1 affecting DNA-binding rather than FOG-1 interaction
40. Allogeneic bone marrow transplantation for agnogenic myeloid metaplasia: French Society of Bone Marrow Transplantation
41. Age and sex distributions of hematological malignancies in the U.K.